epiduo geel
galderma international - adapaleen+bensoüülperoksiid - geel - 1mg+25mg 1g 90g 1tk; 1mg+25mg 1g 45g 1tk; 1mg+25mg 1g 5g 1tk; 1mg+25mg 1g 60g 1tk; 1mg+25mg 1g 15g 1tk; 1mg+25mg 1g 30g 1tk
epiduo geel
galderma international - adapaleen+bensoüülperoksiid - geel - 3mg+25mg 1g 30g 1tk; 3mg+25mg 1g 15g 1tk; 3mg+25mg 1g 5g 1tk; 3mg+25mg 1g 45g 1tk; 3mg+25mg 1g 2g 1tk
differin geel
galderma international - adapaleen - geel - 1mg 1g 5g 1tk; 1mg 1g 30g 1tk
differin kreem
galderma international - adapaleen - kreem - 1mg 1g 5g 1tk; 1mg 1g 30g 1tk
differin kreem
ideal trade links uab - adapaleen - kreem - 1mg 1g 30g 1tk; 1mg 1g 30g 2tk
insulin human winthrop
sanofi-aventis deutschland gmbh - insulin human - diabeet mellitus - diabeetis kasutatavad ravimid - suhkurtõbi, kus on vaja insuliiniravi. insuliini inimese winthrop kiire sobib ka millega kaasnes hüperglükeemiline kooma ja ketoatsidoos, samuti saavutada enne, intra - ja postoperatiivne stabiilsuse patsientidel, kellel.
degarelix accord
accord healthcare s.l.u. - degarelix acetate - eesnäärmevähk - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
bupaq multidose süstelahus
vetviva richter gmbh - buprenorfiin - süstelahus - 0,3mg 1ml 10ml 10tk; 0,3mg 1ml 10ml 1tk; 0,3mg 1ml 10ml 5tk